North America Dental Membrane and Bone Graft Substitute Market – Industry Trends and Forecast to 2030

North America Dental Membrane and Bone Graft Substitute Market Analysis and Size

According to data from the Centers for Disease Control and Prevention, 47.2% of adults 30 and older have periodontal disease. Age is a factor in the development of this condition; 70.1% of those 65 and older have periodontal disease. Thus the bone graft substitutes are used for preventing the gums from expanding into bones during healing and it acts as a barrier. Other factors anticipated to propel the global dental membrane and bone graft substitutes market during the forecast period include rising oral health awareness, an increase in oral disease, increased research and development (R&D) activities and increased use of resorbable dental membranes and bone graft biomaterials

Data Bridge Market Research analyses that the dental membrane and bone graft substitute market which is USD 336.56 million in 2022, is expected to reach USD 690.56 million by 2030, at a CAGR of 9.4% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

North America Dental Membrane and Bone Graft Substitute Market Scope and Segmentation  

Market Definition

Dental membranes and bone graft substitutes are used in dental bone regeneration procedures for periodontal disease and oral cancer patients. Dental membranes are used in conjunction with dental bone grafts to promote cell proliferation during the regeneration process. A bone graft is a material that can be implanted and used to promote bone formation, bone healing, osseous reconstruction, and other procedures. These bone graft materials are used in bone grafting surgical procedures to replace damaged or missing bone (bone graft).

North America Dental Membrane and Bone Graft Substitute Market Dynamics

Drivers

• High incidence of periodontal disorders

The growing incidence of oral health disorders such as oral cancer and periodontal disease is expected to propel the dental membranes and bone graft substitute market forward. For instance, according to the article Assessment of the Status of National Oral Health Policy in India, published in 2015 by the National Center for Biotechnology Information (NCBI). The prevalence of oral diseases in India is very high, with dental caries being the most common. In people aged 5, 12, 15, 35-44, and 65-74, the prevalence is 50.0%, 52.5%, 61.4%, 79.2%, and 84.7%, respectively.

• Increased product development

Most of the manufacturers focused on the development of new products and meet the demand for effective therapeutics which is going to drive the market growth during the forecast period.

For instance, the National Oral Health Survey of India found that the prevalence of periodontal diseases was around 79.9% in people aged 65 to 74 years, while the incidence of oral cancer in India was around 12.6 per 100,000 people in 2016-2017.

Opportunities

• Increasing Elderly Population

Around the World - The World Bank estimates that there were 747,238,580 people over 60 in the world as of the end of 2021. In the upcoming years, the quantity is anticipated to rise. Older persons are more likely to experience oral health issues. Dental conditions such as edentulism are more common in older adults. Therefore, it is anticipated that throughout the forecast period, the global market for dental membrane and bone graft substitutes will rise due to the increasing acceptance of dental implants among the growing older population.

Restraints/Challenges

• Higher Cost Associated with Bone Graft Surgeries

Autografts are mainly utilized for extremely small bone defects due to their higher surgical costs and increased surgical risks, such as excessive bleeding, infection, inflammation, and discomfort. By 2021, it is estimated that 2.2 million bone transplant surgeries performed worldwide at an estimated cost of USD 664 million, with the number of operations to cure bony anomalies expected to rise by about 13% annually.

This dental membrane and bone graft substitute market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the dental membrane and bone graft substitute market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on the Dental Membrane and Bone Graft Substitute Market

The COVID-19 had a negative effect on the market for dental membrane and bone graft substitute market. Companies are experiencing a setback lockdown, causing disruptions in supply chain activities all over the world. Patient visits have decreased as a result of the worldwide implementation of lockdown restrictions. However, the situation is expected to improve as governments around the world relax regulations for resuming business operations. Furthermore, as elective surgeries and procedures resume soon, the demand for dental membrane and bone graft substitutes is expected to rise.

Recent Developments

• In 2021, Nobel Biocare introduced the GalvoSurge Dental Implant Cleaning System, which completely removes biofilm from bacteria-infected titanium implants. It removes biofilm from difficult-to-reach areas of any bacteria-infected titanium implant surface.
• In 2021, Dentsply Sirona announced the acquisition of Datum Dental, Ltd. and its extensive portfolio of OSSIX biomaterials. Datum Dental, based in Israel, is well-known for its cutting-edge dental regeneration solutions, which include the clinically superior GLYMATRIX unique technology.

North America Dental Membrane and Bone Graft Substitute Market Scope

The dental membrane and bone graft substitute market is segmented on the basis of product type, material, application and end-use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Dental Membranes
• Resorbable
• Non-resorbable
• Dental Bone Grafts
• Autograft
• Allograft
• Demineralized bone matrix
• Xenograft
• Synthetic bone graft substitutes
• Bio OSS
• Osteograf
• Grafton

 Material

• Hydrogel
• Collagen
• Human Cells Source
• Hydroxyapatite
• Tricalcium Phosphate
• Polytetrafluroethylene

 Application

• Ridge Augmentation
• Socket Preservation
• Periodontal Defect Regeneration
• Implant Bone Regeneration
• Sinus Lift
• Others

 End Use

• Hospitals
• Dental Clinics
• Ambulatory Surgical Centers

North America Dental Membrane and Bone Graft Substitute Market Regional Analysis/Insights

The dental membrane and bone graft substitute market is analyzed and market size insights and trends are provided by country, product type, material, application and end-use as referenced above.

The countries covered in the dental membrane and bone graft substitute market report are U.S., Canada and Mexico in North America.

In North America, the U.S. is growing due to the increasing number of dental problems and presence of major market players and regulatory approvals, and the introduction of innovative dental membrane and bone graft substitute in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The dental membrane and bone graft substitute market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for dental membrane and bone graft substitute market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the dental membrane and bone graft substitute market. The data is available for historic period 2011-2021.

Competitive Landscape and Dental Membrane and Bone Graft Substitute Market Share Analysis

The dental membrane and bone graft substitute market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to dental membrane and bone graft substitute market.

Some of the major players operating in the dental membrane and bone graft substitute market are:

• Zimmer Biomet (U.S.)
• Bioventus (U.S.)
• Synergy Orthopedics (U.S.)
• Ito Co., Ltd. (Japan)
• Boston Scientific Corporation (U.S.)
• BTL (Canada)
• Cyberonics, Inc. (U.S.)
• DJO LLC (U.S.)
• Medtronic (Ireland)
• Nevro Corp (U.S.)
• NeuroMetrix, Inc (U.S.)
• Abbott (U.S.)
• Uroplasty Inc (U.S.)
• Cogentix Medical (U.S.)
• Aleva Neurotherapeutics (Switzerland)
• NeuroPace Inc (U.S.)
• AxioBionics (U.S.)
• Beurer GmbH (Germany)
• Omron Healthcare, Inc (Japan)
• RS Medical (Japan)
• Stryker (U.S.)

SKU-55361